Back to all studies
UnknownNCT01212848

Safety study of transcranial Magnetic Stimulation in PTSD

This study has an unknown status in the United States. It is testing transcranial Magnetic Stimulation for PTSD.

Suicidality, PTSD, ...DeviceFrom 18 Years to 70 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT01212848. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether brain stimulation may be useful for adults experiencing suicide prevention.

What would participation involve?

Participants may take part in brain stimulation, complete questionnaires or follow-up assessments, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with suicide prevention.

What should you check before joining?

Ask about how many sessions are required and who delivers them, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateOctober 2010
Recruitment status
Unknown
Estimated enrollment
42
Sponsor
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
PHASE3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT01212848
Official title
A Pilot Safety and Feasibility Study of High Dose Left Prefrontal Transcranial Magnetic Stimulation (TMS) to Rapidly Stabilize Suicidal Patients With PTSD
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT01212848. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

Based on the public registry summary, this study is trying to understand: The purpose of this study is to determine whether transcranial magnetic stimulation (TMS) is effective in the treatment of suicidal thinking in individuals with a depressive episode and either posttraumatic stress disorder (PTSD), history of mild traumatic brain injury (TBI),. The study team can confirm the exact objective and what it means for you.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study involving Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation - Sham Comparator. The listed phase is PHASE3. Ask the study team what that means in practice for safety, monitoring, and criteria.

Who might this study be for?

This study may concern people with suicide prevention; age range: From 18 Years to 70 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Will I need to change, stop, or stabilize my current treatment?

The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The recruitment status is not clearly listed. Check the official registry or contact the study team. The registry lists an estimated enrollment of 42 participants.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me